HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xu Ping Wang Selected Research

Xu Ping Wang Research Topics

Disease

3Atherosclerosis
08/2013 - 05/2011
2Diabetic Nephropathies (Diabetic Nephropathy)
05/2022 - 01/2011
1Osteoporosis
12/2021
1Bone Resorption
12/2021
1Postmenopausal Osteoporosis
12/2021
1Inflammation (Inflammations)
05/2011
1Sclerosis
01/2011

Drug/Important Bio-Agent (IBA)

2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
05/2022 - 01/2011
2Apolipoproteins E (ApoE)IBA
08/2013 - 09/2011
1GlucocorticoidsIBA
12/2021
1Polysaccharides (Glycans)IBA
12/2021
1Angiotensin IIIBA
08/2013
1ApolipoproteinsIBA
09/2011
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
09/2011
1Phosphotransferases (Kinase)IBA
09/2011
1JNK Mitogen-Activated Protein KinasesIBA
09/2011
1Toll-Like Receptor 4IBA
05/2011
1Messenger RNA (mRNA)IBA
05/2011
1Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA
05/2011
1Atorvastatin (Lipitor)FDA Link
05/2011
1Streptozocin (Streptozotocin)FDA Link
01/2011
1Superoxide DismutaseIBA
01/2011
1CreatinineIBA
01/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2011
1CollagenIBA
01/2011
1BuffersIBA
01/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2011
1AlbuminsIBA
01/2011
1Malondialdehyde (Propanedial)IBA
01/2011
1Proteins (Proteins, Gene)FDA Link
01/2011
1Sodium CitrateFDA LinkGeneric
01/2011

Therapy/Procedure

1Therapeutics
12/2021